PANKAJ BANSAL

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology EAU CLAIRE, WI NPI 1508181579

General Payments — all program years on this page

$3,009.42

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 159
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $407.42 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $407.4221

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
UCB, Inc. $94.616
Amgen Inc. $89.844
Organon LLC $48.172
PFIZER INC. $34.782
Novo Nordisk AS $34.672
Lilly USA, LLC $24.781
Acerta Pharma LLC $24.581
ABBVIE INC. $20.331
GlaxoSmithKline, LLC. $18.001
Janssen Pharmaceuticals, Inc $17.661

By program year

Program yearAmountRecords
2018 $121.411
2022 $48.192
2023 $2,432.40135
2024 $407.4221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078247567 Janssen Pharmaceuticals, Inc $17.66 04/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096628273 Novo Nordisk Inc $19.42 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097393174 Novo Nordisk Inc $15.25 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103276359 ABBVIE INC. $20.33 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105758105 AstraZeneca Pharmaceuticals LP $24.58 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115439325 Amgen Inc. $22.05 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115439329 Amgen Inc. $22.05 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116532882 GlaxoSmithKline, LLC. $18.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117501130 Amgen Inc. $18.44 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117501132 Amgen Inc. $27.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131539071 PFIZER INC. $19.29 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131560572 PFIZER INC. $15.49 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135304561 Lilly USA, LLC $24.78 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136220356 Organon Llc $22.45 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136220360 Organon Llc $25.72 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189278 UCB, Inc. $16.13 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189282 UCB, Inc. $17.27 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189287 UCB, Inc. $17.68 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189291 UCB, Inc. $16.58 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189296 UCB, Inc. $13.09 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143189300 UCB, Inc. $13.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.